Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation. The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions.

Elon Musk has announced that his company Neuralink has received approval for a brain implant called "Blindsight" that will enable the blind to see again.

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.

Elon Musk's brain-chip startup, Neuralink, has received the US Food and Drug Administration's "breakthrough device" designation

Elon Musk's brain-chip startup has just received its first big win, the breakthrough device, experimental implant, Blindsight got approval from the US Food and

Elon Musk's brain-chip startup Neuralink announces its experimental implant can restore vision, receives US FDA 'breakthrough device' designation.

Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind patients regain their sight, the firm announced Wednesday. Dubbed “Blindsight,” the experimental brain implant gained clearance from the US Food and Drug Administration to participate in the voluntary program.

Elon Musk's Neuralink has received FDA clearance for its experimental Blindsight device, designed to restore vision by targeting the brain's visual cortex.

Elon Musk's Neuralink has introduced Blindsight which will provide sight to those who are blind from birth through an experimental vision-restoring implant

Neuralink, a brain-computer interface company founded by Elon Musk, has announced a groundbreaking Blindsight implant that could restore vision to individuals who have lost both eyes. Musk shared this news on Wednesday,